December 2, 2025 10:29 AM
WHO backs use of GLP-1 therapies for obesity, warns access will remain limited
The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which affects more than 1 billion people globally according to the agency. The guidance comes as demand for the class of drugs known as GLP-1 agonists has surged worldwide, and governments are figuring out how to include the blockbuster therapies into public health systems. The first conditional recommend...